Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRed Rock Resources Share News (RRR)

Share Price Information for Red Rock Resources (RRR)

Share Price is delayed by 15 minutes
Get Live Data
0.023    0.00 (0.00%)
Bid:
0.022
Ask:
0.024
Spread: 0.002 (9.091%)
Market Cap: £2.20m
RRR Live PriceLast checked at - London Stock Exchange

Intraday Red Rock Resources Share Chart

Daly buys at BAT

Fri, 01st Oct 2010 16:31
British American Tobacco's chief operating officer John Daly has invested nearly £511,000 in shares in the tobacco company. He has bought 21,200 shares at 2408.57p each and that takes his beneficial stake to 52,417 shares. Daly joined BAT as a result of its merger with Rothmans in 1999. He was appointed as chief operating officer of the group in September at the same time that Nicandro Durante took on the role of chief executive designate. Durante takes over as chief executive next February. Daly was previously regional director for Asia Pacific. In July, BAT said that it expects another year of good growth in both earnings and dividends. Pre-tax profit rose to £2,279m in the six months to 30 June, up from £2,123m in the first half of 2009. The tobacco firm increased its interim dividend from 27.9p a share to 33.2p a share.Top Director BuysBritish American Tobacco (BATS) Director name: Mr John DalyAmount purchased: 21,200 @ 2,408.57p Value: £510,617PSG Solutions (PGS) Director name: Mr Bernard Cavan ConnorAmount purchased: 300,000 @ 24.00p Value: £72,000GlaxoSmithKline (GSK) Director name: Dr Dr Dan PodolskyAmount purchased: 2,078 @ 1,265.19p Value: £26,291GlaxoSmithKline (GSK) Director name: Sir Christopher GentAmount purchased: 2,685 @ 1,257.00p Value: £33,750Ascent Resources (AST) Director name: Mr Jeremy EngAmount purchased: 699,815 @ 4.38p Value: £30,652GlaxoSmithKline (GSK) Director name: Mr Lawrence CulpAmount purchased: 1,539 @ 1,265.19p Value: £19,471Cyan (CYAN) Director name: Dr John ReadAmount purchased: 3,088,221 @ 0.90p Value: £27,794Cyan (CYAN) Director name: Mr Simon Smith Amount purchased: 2,777,778 @ 0.90p Value: £25,000GlaxoSmithKline (GSK) Director name: Sir Sir Crispin H L DavisAmount purchased: 1,889 @ 1,257.00p Value: £23,745Unilever (ULVR) Director name: Ms Ann M FudgeAmount purchased: 700 @ 1,849.80p Value: £12,949Top Director SellsCentamin Egypt (CEY) Director name: Mr Stuart BottomleyAmount sold: 200,000 @ 179.78p Value: £359,560Centamin Egypt (CEY) Director name: Mr Stuart BottomleyAmount sold: 200,000 @ 178.26p Value: £356,520BrainJuicer Group (BJU) Director name: Mr James GeddesAmount sold: 125,000 @ 200.00p Value: £250,000Centamin Egypt (CEY) Director name: Mr Stuart BottomleyAmount sold: 100,000 @ 177.91p Value: £177,910Red Rock Resources (RRR) Director name: Mr Andrew Ronald McMillan BellAmount sold: 1,000,000 @ 6.09p Value: £60,900Oxford Instruments (OXIG) Director name: Mr Charles HolroydAmount sold: 6,016 @ 500.45p Value: £30,107

Related News

IN BRIEF: Ascent Resources shares fall as annual results delayed
4 days ago

IN BRIEF: Ascent Resources shares fall as annual results delayed

Ascent Resources PLC - oil and gas exploration and production firm with principal assets in Slovenia and the US - Says the in-progress audit of its 20...

GSK drug momelotinib gains regulatory nods as VEXAS treatment
4 days ago

GSK drug momelotinib gains regulatory nods as VEXAS treatment

(Alliance News) - GSK PLC on Friday announced that momelotinib has received orphan drug designation from the US Food & Drug Administration, and the Eu...

GSK's momelotinib receives orphan drug designation from US and EU watchdogs
4 days ago

GSK's momelotinib receives orphan drug designation from US and EU watchdogs

(Sharecast News) - Drugmaker GSK said on Friday that its JAK inhibitor momelotinib has been granted orphan drug designation by both the US Food and Dr...

Red Rock Resources News

WINNERS & LOSERS: Diales earnings rise; Mirriad warns of liquidation
23 Apr 2026

WINNERS & LOSERS: Diales earnings rise; Mirriad warns of liquidation

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.

EARNINGS AND TRADING: Fermi secures USD156 million in funding
1 Apr 2026

EARNINGS AND TRADING: Fermi secures USD156 million in funding

The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance Ne...

WINNERS & LOSERS: Ferrexpo warns on cash; Deltic takeover is abandoned
1 Apr 2026

WINNERS & LOSERS: Ferrexpo warns on cash; Deltic takeover is abandoned

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.

Red Rock Resources in 'stretched' financial position as losses widen
1 Apr 2026

Red Rock Resources in 'stretched' financial position as losses widen

(Sharecast News) - Red Rock Resources reported a wider first-half loss and highlighted a stretched financial position on Wednesday, as it awaits progr...

EARNINGS AND TRADING: Unigel profit surges, outlook "promising"
11 Feb 2026

EARNINGS AND TRADING: Unigel profit surges, outlook "promising"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

Red Rock signs NDA over potential DRC copper-cobalt project
11 Feb 2026

Red Rock signs NDA over potential DRC copper-cobalt project

(Sharecast News) - Red Rock Resources said on Wednesday that it has signed a non-disclosure agreement and begun due diligence on a privately held copp...

Red Rock Resources widens loss but expects more cash to come
22 Dec 2025

Red Rock Resources widens loss but expects more cash to come

(Alliance News) - Red Rock Resources PLC on Monday reported a widened loss for the year ended June 30, but expects cash generation "over the next few ...